Claudia Trignano

Dr. Claudia Trignano

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in Toxics
Verified
Journal Article
Open access
PDF file
AAAntonina Argo
Antonina Argo
SZStefania Zerbo
Stefania Zerbo
RBRoberto Buscemi
Roberto Buscemi
Claudia TrignanoClaudia Trignano
Claudia Trignano
Elisabetta BertolElisabetta Bertol
Elisabetta Bertol
FVFabio Vaiano
Fabio Vaiano
The best evidence provided in the literature worldwide suggests the importance of harmonizing the investigation in drug-related fatalities. In this study, the application of a multidisciplinary approach in eight cases of drug-related deaths is presented. Although death scene findings could be highly suggestive of drug intoxication, external examination and toxicological screening test alone are insufficient. There are several variables, and it is not always easy to give the proper interpretation of the drug detection. A complete autopsy is necessary to correctly complete organ and tissues sampling for further histological and toxicological studies and obtain body fluids. The use of peripheral blood is recommended to avoid artifacts. The collection of many specimens is warranted to get more responses. The sampling aims to provide a picture of the distribution of the substance in the body. The sample and the selection of the drugs and the matrices to investigate are case-dependent. The presented diagnostic algorithm provides the coroner with all the elements to investigate drug-related deaths and cooperate with toxicologists. Toxicological forensic diagnosis is still extremely heterogeneous in regional and national contexts. Funding for method development, research, networking, facilities, and technologies improvement is mandatory to standardize the toxicological investigation.

14 June 2023 in Aesthetic Plastic Surgery
Verified
Journal Article
Open access
PDF file
MTMatilde Tettamanzi
Matilde Tettamanzi
NPNicola Pili
Nicola Pili
MRManuela Rodio
Manuela Rodio
PSPietro Luciano Serra
Pietro Luciano Serra
Claudia TrignanoClaudia Trignano
Claudia Trignano
ETEmilio Trignano
Emilio Trignano
Background: Body contouring surgery is increasingly requested by patients, both for aesthetic and post-bariatric purposes. There has also been a rapid increase in demand for noninvasive aesthetic treatments. While brachioplasty is burdened by numerous complications and unsatisfactory scars, and conventional liposuction is unsuitable for all patients, nonsurgical arm remodeling performed with radiofrequency-assisted liposuction (RFAL) allows to effectively treat most of patients, regardless of the amount of fat and ptosis of the skin and avoiding surgical excision. Methods: A prospective study was conducted on 120 consecutive patients who presented to the author's private clinic and required upper arm remodeling surgery for aesthetic purposes or after weight loss. Patients were classified according to the modified classification of El Khatib and Teimourian. Pre- and posttreatment upper arm circumferences were taken after 6 months of follow-up to assess the degree of skin retraction obtained by treating the arm with RFAL. A satisfaction questionnaire regarding the appearance of the arms (Body-Q upper arm satisfaction) was administered to all patients before surgery and after 6 months of follow-up. Results: All patients were effectively treated with RFAL, and no cases required conversion to brachioplasty. The average reduction in arm circumference was 3.75 cm at 6 months follow-up, and patients’ satisfaction increased from 35 to 87% posttreatment. Conclusions: Radio frequency is a valid tool to treat most patients with upper limbs skin laxity, with significant aesthetic results and a high degree of patient satisfaction, regardless of the degree of skin ptosis and lipodystrophy of the arm. Level of Evidence IV: This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

1 March 2014 in Legal Medicine
Verified
Journal Article
Closed access
MNMaria Nieddu
Maria Nieddu
LBLucia Burrai
Lucia Burrai
Claudia TrignanoClaudia Trignano
Claudia Trignano
GBGianpiero Boatto
Gianpiero Boatto

7 December 2021 in Toxics
Verified
Journal Article
Open access
PDF file
Elisabetta BertolElisabetta Bertol
Elisabetta Bertol
FVFabio Vaiano
Fabio Vaiano
AAAntonina Argo
Antonina Argo
SZStefania Zerbo
Stefania Zerbo
Claudia TrignanoClaudia Trignano
Claudia Trignano
DFDonata Favretto
Donata Favretto
Quetiapine is an atypical antipsychotic drug used to treat bipolar disorder, schizophrenia, and major depressive disorder. Although several studies describe the adverse effects of intoxication with Quetiapine, only a few report an extreme overdose without comedications that lead to a life threat. We present a case of a 75-year-old male who tried to attempt suicide by ingesting 28 g of Quetiapine. During the management in the emergency department, both serum and urine samples were collected, allowing a complete pharmacokinetic analysis to be conducted, from the admission to the discharge.

11 January 2022 in International journal of legal medicine
Verified
Journal Article
Open access
PDF file
ACAlberto Chighine
Alberto Chighine
MPMichele Porcu
Michele Porcu
GFGiulio Ferino
Giulio Ferino
NLNicola Lenigno
Nicola Lenigno
Claudia TrignanoClaudia Trignano
Claudia Trignano
ELEmanuela Locci
Emanuela Locci
A case report suspicious for a Sudden Infant Death Syndrome is here described. Pathological findings were consistent with an acute respiratory failure while toxicological analysis revealed an elevated blood methadone concentration. Death was then ascribed to an acute methadone intoxication. In addition to the routinary approach, the urinary sample collected at autopsy was investigated with a 1H NMR metabolomic approach and the identified metabolomic profile was challenged with the urinary metabolomic profiles previously obtained from 10 newborns who experienced perinatal asphyxia and 16 healthy control newborns. Intriguingly, the urinary profile of the methadone intoxicated infant was very similar to those belonging to the perinatal asphyxia newborns, especially to those belonging to the newborns characterised by the worst outcome. The results offer several hints on a shared metabolic derangement between different mechanisms of asphyxia/hypoxia. To the best of the authors’ knowledge, this is the first report of the use of a metabolomic approach in a pathological case, in which metabolomics offers useful additional information regarding the mechanism and the cause of death.

11 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FZFederico Ziani
Federico Ziani
MTMatilde Tettamanzi
Matilde Tettamanzi
GAGiovanni Arrica
Giovanni Arrica
RCRoberto Cuomo
Roberto Cuomo
EFEdoardo Filigheddu
Edoardo Filigheddu
ETEmilio Trignano
Emilio Trignano
Background: Tumescent local anesthesia (TLA) is widely used in esthetic surgery due to its ability to reduce complications, eliminate the need for general anesthesia, provide effective pain control, and shorten hospitalization times. Methods: This study evaluates the use of TLA in 80 patients who underwent augmentation mastopexy between 2010 and 2022. A tumescent solution containing 500 mg lidocaine, 672 mg sodium bicarbonate, and 1 mg epinephrine in 1000 mL of saline was infiltrated, with an average of 300 mL per breast. The surgical technique involved creating a subpectoral pocket for textured round implants (250–400 cc), followed by careful hemostasis. Results: No patients required conversion to general anesthesia, and there were no signs of toxicity or major complications. Minor complications included wound dehiscence (6.2%), hematoma (2.5%), and capsular contracture (2.5%). Pain management satisfaction at 3 months post-surgery was rated as “outstanding” by 12.5% of patients, “excellent” by 67.5%, and “good” by 20%. The longest follow-up was 6 years, with no implant ruptures except one (1.2%). Conclusions: While the study did not include a control group or statistical analysis, the findings suggest that TLA is a safe and effective alternative to general anesthesia for augmentation mastopexy, providing excellent pain control and a low rate of complications.